Samuel S. Bado

Samuel Bado practices at Chest Medicine Associates, PA in South Portland, Maine.

Samuel Bado's NPI, 1760048847, was assigned on May 14, 2019. Samuel Bado graduated from Des Moines University of Osteopathic Medicine and Health Sciences in 2019. Samuel Bado holds Maine license DO3570.

Samuel Bado's primary practice is Chest Medicine Associates, PA, at 100 Foden Rd, South Portland, ME 04106 in Cumberland County. The practice phone is (207) 828-1122.

Samuel Bado's primary practice is Chest Medicine Associates, PA in South Portland, Maine. Samuel Bado is also affiliated with MaineGeneral Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Samuel Bado to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samuel Bado practices, 4 sites in all. Vendor and product names are available with a free account.

Pediatrics is Samuel Bado's primary specialty in the NPI Registry, under taxonomy code 2080S0012X. The record also lists sleep medicine. Samuel Bado is licensed in Maine.

CMS data shows 286 Medicare services from Samuel Bado across 9 procedure codes in 2024, for 230 Medicare patients. Medicare paid $42,606 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Samuel Bado in 2024. The largest group is 65 to 74, with 100 patients. 69% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Samuel Bado's median patient age at 66, with 48% women.

In 2024, Samuel Bado wrote 123 Medicare Part D claims for 21 patients. 83% of them were for generic drugs. CMS names the drug for 63 of them, across 4 drugs with 11 or more claims each, at $465 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Samuel Bado for performance year 2024, reported through an alternative payment model (APM). Samuel Bado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Samuel Bado from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Jazz Pharmaceuticals Inc. paid the most, $150.

Samuel Bado graduated from Des Moines University of Osteopathic Medicine and Health Sciences in 2019.